Showing results (271-280 of 938) with videos related to
Sort By:
Pageof 94
Neuroscience Letters|March 8, 1996
Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineK S McNaught, U Thull, P A Carrupt, et al.Biochemical Pharmacology|June 14, 1996
Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respirationK S McNaught, U Thull, P A Carrupt, et al.Journal of the Neurological Sciences|July 17, 1998
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseasesM Gu, A D Owen, S E Toffa, et al.Journal of Neurochemistry|December 1, 1990
Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's diseaseA H Schapira, V M Mann, J M Cooper, et al.Annals of Neurology|October 1, 1992
Alpha-tocopherol levels in brain are not altered in Parkinson's diseaseD T Dexter, R J Ward, F R Wells, et al.Parkinsonism & Related Disorders|July 2, 2008
Genetic susceptibility and the occurrence of Parkinson's diseaseP JennerPathologie-Biologie|January 1, 1996
Oxidative stress in Parkinson's disease and other neurodegenerative disordersP JennerNeurology|March 1, 1995
The rationale for the use of dopamine agonists in Parkinson's diseaseP JennerPageof 94